Leavitt, 27, noted in her first White House briefing that Trump, 78, remains “firm in his decision” to cut off federal funding for the 24-hour protection Bolton, Pompeo and former US Special
The National Institutes of Health had funded protection for the former director of the National Institute of Allergy and Infectious Diseases (NIAID).
Director Dr. Anthony Fauci has been stripped of his federal security detail despite ongoing death threats over his role in the COVID-19 pandemic. The 84-year-old physician, who stepped down in December 2022 after leading the organization for nearly 40 years,
Dr. Anthony Fauci is the latest ex-aide to lose government protection, reflecting Trump's early moves against perceived adversaries.
President Donald Trump has terminated Dr. Anthony Fauci’s security detail that was being provided and paid for by the National Institutes of Health, a source familiar with the situation tells CNN. It was pulled on Thursday night.
US President Donald Trump terminated the security detail of former Chief Medical Advisor to US President, Anthony Fauci on Thursday that was being provided and paid for by the National Institutes of Health,
President Donald Trump has revoked government security protection for former Secretary of State Mike Pompeo and his top aide, Brian Hook.
President Donald Trump confirmed that he has revoked the security detail provided to Dr. Anthony Fauci by the National Institutes of Health at taxpayer expense.
President Donald Trump has terminated Dr. Anthony Fauci’s security detail that was being provided and paid for by the National Institutes ... Secretary of State Mike Pompeo.
Security detail for former director of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, has been nixed
Defense Secretary Pete Hegseth on Tuesday revoked the security detail and security clearance for Gen. Mark Milley, according to Pentagon spokesman John Ullyot, an unprecedented move against the former top US general who became a frequent target of President Donald Trump.
A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research and the like.